<DOC>
	<DOCNO>NCT00320632</DOCNO>
	<brief_summary>This study determine effectiveness desipramine improve cellular signaling , thereby decrease symptom depression people major depressive disorder ( MDD ) .</brief_summary>
	<brief_title>Desipramine Improving Cellular Signaling Decreasing Symptoms Major Depression</brief_title>
	<detailed_description>MDD serious mental illness interfere person 's ability eat , sleep , work , enjoy activity pleasurable . It characterize several symptom , include follow : persistent sad , anxious , `` empty '' mood ; feeling hopelessness pessimism ; feeling guilt , worthlessness , helplessness . The receptor-G protein-adenylate cyclase enzyme complex ( AC enzyme complex ) major cell signal system brain , blood , tissue body . Changes signal system among blood cell observe people major depressive disorder . Research show treatment benzodiazepine alprazolam corrects signal problem , thereby improve symptom MDD . This study determine whether impairment AC enzyme complex exist among depressed individual . This study also evaluate effectiveness desipramine , antidepressant , improve blood cell signal , thereby decrease symptom depression people major depressive disorder . Both healthy depress participant recruit study . All depress participant study first assess depression severity use Hamilton Depression Rating Scale . If eligible study , participant examine determine AC enzyme complex function platelet mononuclear leukocyte . A cohort depress participant treated desipramine . They examine determine drug 's effect AC enzyme complex functioning , well effect MDD symptom , Weeks 1 , 4 , 6 .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Desipramine</mesh_term>
	<criteria>Clinical diagnosis MDD ( define SCID [ DSM IIIR ] score least 15 21item Hamilton Depression Scale ) Able swallow tablet , give urine blood sample , participate periodic evaluation study Healthy volunteer show current Axis I Axis II disorder score less 8 Hamilton Depression Scale Use follow medication within 2 week prior study entry : psychoactive medication ; aspirin ; nonsteroidal antiinflammatory agent Any alcohol drug abuse within 6 month prior study entry Any major medical disorder</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>MDD</keyword>
</DOC>